In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s. Listen now to hear the findings and what this means for future clinical practice! Further reading: You can read this article [https://doi.org/10.1093/rheumatology/keae585] in Rheumatology. Thanks for listening to T...
All content for Talking Rheumatology Research is the property of British Society for Rheumatology and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s. Listen now to hear the findings and what this means for future clinical practice! Further reading: You can read this article [https://doi.org/10.1093/rheumatology/keae585] in Rheumatology. Thanks for listening to T...
Ep 39. UK JIA Biologics Register: stopping biologics for remission
Talking Rheumatology Research
10 minutes
1 year ago
Ep 39. UK JIA Biologics Register: stopping biologics for remission
What happens when children and young people with JIA stop biologic therapies for remission? Dr Lianne Kearsley-Fleet and Dr Coziana Ciurtin join Dr Herman Tam to discuss their analysis of the UK JIA Biologics Register. Lianne is an epidemiologist and lead analyst of the UK JIA Biologics Register, based at the University of Manchester. Coziana is a consultant rheumatologist based at University College London. Managed by the University of Manchester, the UK JIA Biologics Register is a collabora...
Talking Rheumatology Research
In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s. Listen now to hear the findings and what this means for future clinical practice! Further reading: You can read this article [https://doi.org/10.1093/rheumatology/keae585] in Rheumatology. Thanks for listening to T...
